John F Seymour
机构: Professor of Medicine, Director Dept of Haematology Peter MacCallum Cancer Centre & Royal Melbourne
主页: petermac.org
每年引用次数
引用次数
引用: 66,887
H-指数: 121
I10-指数 : 515
出版物: 1,147
Dancing partners at the ball: Rational selection of next generation anti-CD20 antibodies for combination therapy of chronic lymphocytic leukemia in the novel agents era.
L.A. Butler , C.S. Tam , J.F. Seymour
Blood Reviews 31 ( 5) 318 -327
7
2017
Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study
A. Wirth , M. Gospodarowicz , B.M.P. Aleman , M. Bressel
Annals of Oncology 24 ( 5) 1344 -1351
91
2013
Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy
B.A. Campbell , C. Hornby , J. Cunninghame , M. Burns
Annals of Oncology 23 ( 5) 1259 -1266
45
2012
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
F. Morschhauser , J.F. Seymour , H.C. Kluin-Nelemans , A. Grigg
Annals of Oncology 19 ( 2) 247 -253
87
2008
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
G. Ryan , G. Martinelli , M. Kuper-Hommel , R. Tsang
Annals of Oncology 19 ( 2) 233 -241
299
2008
Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab
M.J. Bishton , M.F. Leahy , R.J. Hicks , J.H. Turner
Annals of Oncology 19 ( 9) 1629 -1633
13
2008
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group
G. Martinelli , G. Ryan , J.F. Seymour , L. Nassi
Annals of Oncology 20 ( 12) 1993 -1999
70
2009
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy
S. Gill , D. Carney , D. Ritchie , M. Wolf
Annals of Oncology 21 ( 2) 331 -334
32
2010
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
F. Morschhauser , P. Marlton , U. Vitolo , O. Lindén
Annals of Oncology 21 ( 9) 1870 -1876
98
2010
Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy
S. Brennand , V.R. Sutton , J. Biagi , J.A. Trapani
British Journal of Dermatology 152 ( 6) 1199 -1205
12
2005
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
U. Vitolo , J.F. Seymour , M. Martelli , G. Illerhaus
Annals of Oncology 27
50
2016
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.
M.J. Maurer , T.M. Habermann , Q. Shi , N. Schmitz
Annals of Oncology 29 ( 8) 1822 -1827
28
2018
INTERSTITIAL LUNG DISEASE | Alveolar Proteinosis
J.J. Presneill , K. Nakata , J.F. Seymour
Encyclopedia of Respiratory Medicine 412 -419
2006
Pegylated liposomal doxorubicin in the treatment of cutaneousT-cell lymphoma
H.Miles Prince , J.F. Seymour , Gail Ryan , Chris McCormack
Journal of The American Academy of Dermatology 44 ( 1) 149
7
2001
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes
C.Y. Cheah , D. Chihara , J.E. Romaguera , N.H. Fowler
Annals of Oncology 26 ( 6) 1175 -1179
83
2015
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment
R. Blum , J.F. Seymour , G. Toner
Annals of Oncology 13 ( 2) 327 -330
23
2002
Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia
P. Mollee , C. Arthur , T. Hughes , H. Januszewicz
Annals of Oncology 15 ( 12) 1810 -1815
6
2004
"Reversible" myelodysplastic syndrome or ineffectual clonal haematopoiesis? - add(6p) myeloid neoplasm with a spontaneous cytogenetic remission.
K. Rady , P. Blombery , D.A. Westerman , M. Wall
Leukemia Research 73 1 -4
2018
Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma
S.L. Chua , J.F. Seymour , J. Streater , M.M. Wolf
Leukemia & Lymphoma 43 ( 9) 1783 -1788
58
2002
Diffuse large B-cell non-Hodgkin's lymphoma presenting as Sister Joseph's nodule.
C. Tam , H. Turner , R.J. Hicks , J.F. Seymour
Leukemia & Lymphoma 43 ( 10) 2055 -2057
12
2002